Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Carlos V. Payá, Atul Humar, Ed Dominguez et al. · American Journal of Transplantation · 2004 · 876 citations · Full text

American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation

Atul Humar, Marian G. Michaels · American Journal of Transplantation · 2006 · 478 citations

Transplant Rejection, Transplantation, Medicine +7

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Anders Åsberg, Atul Humar, Halvor Rollag et al. · American Journal of Transplantation · 2007 · 421 citations

Intravenous Ganciclovir, Transplantation, Cytomegalovirus Disease +4

Posttransplant Lymphoproliferative Disease in Primary Epstein‐Barr Virus Infection after Liver Transplantation: The Role of Cytomegalovirus Disease

Rafael Máñez, Mary C. Breinig, Peter Linden et al. · The Journal of Infectious Diseases · 1997 · 249 citations · Full text

Monitoring of Human Cytomegalovirus-Specific CD4+ and CD8+ T-Cell Immunity in Patients Receiving Solid Organ Transplantation

Giuseppe Gerna, Daniele Lilleri, Chiara Fornara et al. · American Journal of Transplantation · 2006 · 179 citations · Full text